Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine
Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine
Active, not recruiting · NCT07291635 · Registry updated 2026-08-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-04 | NCT07291635 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aramis Biotechnologies Inc. | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Canadian Center for Vaccinology (CCfV) - IWK Health | Halifax | Canada | 1 |
| CHU de Québec - Université Laval | Québec | Canada | 1 |
| Diex Recherche - Sherbrooke | Sherbrooke | Canada | 1 |
| Diex Recherche - Trois-Rivières | Trois-Rivières | Canada | 1 |
| Diex Recherche - Victoriaville | Victoriaville | Canada | 1 |
| Montreal Heart Institute | Montreal | Canada | 49 |
| Vaccine Study Centre of McGill University Health Centre | Pierrefonds | Canada | 1 |